Nexstim Plc: Invitation to the Extraordinary General Meeting
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) invites shareholders to the Extraordinary General Meeting of the Company to decide on authorizations for the Board of Directors to decide on share issues and issuances of option rights and special rights to shares. The Extraordinary General Meeting will be held on Monday, March 1, 2021 commencing at 1 PM (EET) at the Nexstim Headquarters, Elimäenkatu 9 B (inner court), 4
th floor, 00510 Helsinki. The reception of persons who have registered for the meeting will commence at 12.30 PM (EET). Since the risk of getting infected by coronavirus is still significant, all shareholders are strongly encouraged to exercise their voting rights by proxy representation by the General Counsel of the Company. More information and instructions on authorising by proxy is available on the Company website
Nexstim Oyj: Nexstim Plc Announces Resolutions of the Shareholder s Nomination Board
Nexstim Plc Announces Resolutions of the Shareholder s Nomination Board
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces resolutions of its Shareholder s Nomination Board.
Rohan Hoare, who has been a member of Nexstim s Board of Directors since 2016, and Tomas Holmberg, who has been a member of Nexstim s Board of Directors since 2017, have announced that they will no longer be available to the company s Board of Directors for the period 2021-2022. At its meeting, the Nomination Board of the Company has decided to propose to the General Meeting Timo Hildén and Tero Weckroth as new members of the Board.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Finnish startup Surgify Medical raises €1.4 million. looking for international breakthrough with safer surgical technology
Surgify Medical Oy, a Finnish company that develops safer surgical technology, has raised €1.4 million in funding from both domestic and foreign investors.
In addition to existing backers, among the investors in the startup’s third investment round were Finnish venture capital investor Innovestor Ventures, Swedish investor Peter Lindell, and well-known Finnish angel investor and healthcare entrepreneur Leena Niemistö. The funding will be used to bring Surgify’s safer surgical drill to market.
Surgify’s internationally recognised technology is intended to prevent nerve and blood vessel injuries caused by surgical drills. The company believes that technology plays an important role in saving lives and making bone surgery safer. Furthermore, the time and money spent on surgeries could be decreased considerably. In addition to performing various surgica